World News | Reuters | Tuesday January 19, 2021
A candidate COVID-19 vaccine known as EpiVacCorona, Russia's second to be registered, proved "100% effective" in early-stage trials, Russian consumer health watchdog Rospotrebnadzor has told local media.
www.ndtv.com